Issue 99, 2014

Nucleic acid binding study of surfactant copper(ii) complex containing dipyrido[3,2-a:2′-3′-c]phenazine ligand as an intercalator: in vitro antitumor activity of complex in human liver carcinoma (HepG2) cancer cells

Abstract

A new surfactant copper(II) complex, [Cu(dppz)2DA](ClO4)2, where dppz = dipyrido[3,2-a:2′-3′-c]phenazine and DA-dodecylamine, has been synthesized and characterized by physico-chemical and spectroscopic methods. The critical micelle concentration (CMC) value of this surfactant copper(II) complex in aqueous solution was determined from conductance measurements. Specific conductivity data at different temperatures was obtained for the evaluation of the temperature-dependent CMC and the thermodynamics of micellization (ΔG0m, ΔH0m and ΔS0m). The binding interaction of this complex with nucleic acids (calf thymus DNA and yeast t-RNA) was investigated using electronic absorption, fluorescence spectroscopy, viscometry, cyclic voltammetry (CV) and thermal denaturation studies. In the presence of the nucleic acids, the UV-Vis spectrum of our complex exhibited a redshift of the absorption band at 268 nm along with significant hypochromicity, indicating intercalation of our complex with the nucleic acids. The intrinsic binding constant values are Kb = 1.1 × 106 M−1 for DNA and 1.6 × 106 M−1 for RNA. The viscosity measurements confirmed that the complex–nucleic acid interaction occurs through intercalation. A competitive binding study with ethidium bromide (EB) showed that the complex exhibits the ability to displace the nucleic acid-bound EB, indicating that the complex binds to nucleic acids in strong competition with EB for the intercalative binding site. CV results also confirmed this mode of binding. Some significant thermodynamic parameters of the binding of the titled complex to DNA were also determined. The antimicrobial and antifungal screening tests of this complex have shown good results. The copper(II) complex exhibited pronounced activity against a human liver carcinoma (HepG2) cancer cell line.

Graphical abstract: Nucleic acid binding study of surfactant copper(ii) complex containing dipyrido[3,2-a:2′-3′-c]phenazine ligand as an intercalator: in vitro antitumor activity of complex in human liver carcinoma (HepG2) cancer cells

Supplementary files

Article information

Article type
Paper
Submitted
03 Aug 2014
Accepted
08 Oct 2014
First published
08 Oct 2014

RSC Adv., 2014,4, 56084-56094

Author version available

Nucleic acid binding study of surfactant copper(II) complex containing dipyrido[3,2-a:2′-3′-c]phenazine ligand as an intercalator: in vitro antitumor activity of complex in human liver carcinoma (HepG2) cancer cells

K. Nagaraj, K. S. Murugan, P. Thangamuniyandi and S. Sakthinathan, RSC Adv., 2014, 4, 56084 DOI: 10.1039/C4RA08049A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements